EUVIMEDEUVIMED entdecken
Crossref

Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates

I Bodis-Wollner, E Chung, M F Ghilardi, A Glover, M Onofrj, P Pasik, Y Samson

Journal of Neural Transmission - Parkinson's Disease and Dementia Section · 1991

DOI: 10.1007/bf02251137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 1991. Verfasst von I Bodis-Wollner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mount Sinai School of Medicine, C.U.N.Y., New York. Hauptthemen laut MEDLINE: MPTP Poisoning. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NEI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetyl-levo-carnitine (ALC) protects against 1-methyl, 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity in the nonhuman primate. ALC pretreated monkeys do not show signs of parkinsonism or electroretinographic changes typical of dopaminergic deficiency when given MPTP. In addition, pilot neurochemical and morphological data confirm a partial protection effect. While MAO-B inhibitors, like L-Deprenyl, are thought to protect dopaminergic neurons from MPTP-induced cell death by preventing the conversion of MPTP to its toxic metabolite MPP+, ALC is not known to have MAO-B affinity. Converging evidence suggests that ALC may affect directly mitochondrial respiration, which is known to be the target of MPP+ and affected in human neurodegenerative diseases, including Parkinson's disease. The results of this study point to new therapeutic avenues for the treatment of these nosologic entities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MPTP PoisoningAcetylcarnitineAnimalsCarbidopaCaudate NucleusElectroretinographyFemaleHomovanillic AcidImmunohistochemistryLevodopaMacaca fascicularisMaleParkinson Disease, SecondarySubstantia Nigra

Substanzen

LevodopaAcetylcarnitineCarbidopaHomovanillic Acid

Autor:innen und Institutionen

  • Department of Neurology, Mount Sinai School of Medicine, C.U.N.Y., New York.

Förderung

  • NEI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Bodis-Wollner, I., Chung, E., Ghilardi, M. F., Glover, A., Onofrj, M., Pasik, P., & Samson, Y. (1991). Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. https://doi.org/10.1007/bf02251137

Vancouver

Bodis-Wollner I, Chung E, Ghilardi MF, Glover A, Onofrj M, Pasik P, et al. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1991. doi:10.1007/bf02251137

BibTeX
@article{BodisWollner1991,
  author = {Bodis-Wollner, I and Chung, E and Ghilardi, M F and Glover, A and Onofrj, M and Pasik, P and Samson, Y},
  title = {Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates},
  journal = {Journal of Neural Transmission - Parkinson's Disease and Dementia Section},
  year = {1991},
  doi = {10.1007/bf02251137}
}
Kostenlos starten →